Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)

References

• Blenkinsopp A, Bond COver-the-counter medication2005HyderabadBMA Publications57
   Google Scholar
• OTC sales statistics | Consumer Healthcare Products Association. [https://www.chpa.org/about-consumer-healthcare/research-data/otc-sales-statistics. Accessed 29 July 2022.
   Google Scholar
• The value of OTC medicines to the U.S. healthcare system | Consumer Healthcare Products Association. https://www.chpa.org/about-consumer-healthcare/research-data/research-reports/value-otc-medicines-us-healthcare-system-0. Accessed 29 July 2022.
   Google Scholar
• Blieden M, Paramore LC, Shah D, Ben-Joseph RA perspective on the epidemiology of acetaminophen exposure and toxicity in the United StatesExpert Rev Clin Pharmacol201473341348 1:CAS:528:DC%2BC2cXmtFWrurc%3D 10.1586/17512433.2014.904744 24678654
   PubMed Web of Science ®Google Scholar
• Moore RA, Moore NParacetamol and pain: the kiloton problemEur J Hosp Pharm2016234187188 10.1136/ejhpharm-2016-000952 31156845 6451482
   PubMedGoogle Scholar
• Joint Formulary Committee. British national formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2022. p. 1792. https://bnf.nice.org.uk/
   Google Scholar
• Councils—committees Cyprus—pharmacy board | Pharmaceutical Services |. https://www.moh.gov.cy/moh/phs/phs.nsf/All/10CA140B2C8BF839C22585AE00359A6E?OpenDocument. Accessed 29 July 2022.
   Google Scholar
• Marketing authorization via national procedure | Pharmaceutical Services. https://www.moh.gov.cy/Moh/phs/phs.nsf/All/EF422CDC80654B99C2258582003E15EF?OpenDocument. Accessed 2 Aug 2022.
   Google Scholar
• Marketing authorisations for medicinal products—licencing procedures | Pharmaceutical Services |. https://www.moh.gov.cy/moh/phs/phs.nsf/All/D7A411F2E214A625C22585820034E8EF?OpenDocument. Accessed 29 July 2022.
   Google Scholar
• Licencing procedures/special marketing authorisation (Article 126a of Directive 2001/83 / EC) | Pharmaceutical Services |. https://www.moh.gov.cy/Moh/phs/phs.nsf/All/A40130D3309953D1C22585850021BBF2?OpenDocument. Accessed 2 Aug 2022.
   Google Scholar
• Pharmaceutical services—medicines for human use (control of quality, supply and pricing) law of 2001 (70(I)/2001) (KDP 465/2017). 2017. p. 10. https://www.moh.gov.cy/moh/phs/phs.nsf/legislationactions_table_el/legislationactions_table_el?openform. Accessed 29 July 2022.
   Google Scholar
• Petrou PThe 2019 introduction of the new National Healthcare System in CyprusHealth Policy20211253284289 10.1016/j.healthpol.2020.12.018 33516561
   PubMed Web of Science ®Google Scholar
• Petrou P, Vandoros SCyprus in crisis: recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatmentHealth Policy20151195563568 10.1016/j.healthpol.2015.03.004 25837234
   PubMed Web of Science ®Google Scholar
• López Vila ED, Buts C, Jegers MA quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systemsJ Pharm Policy Pract2023161111 10.1186/s40545-023-00522-7
   PubMedGoogle Scholar
• Kanavos P, Wouters O. Pharmaceutical policies in Cyprus: a review of the current system and future options. 2014;(August):64. http://www.moh.gov.cy/moh/moh.nsf/All/73AB0132AA5867CDC2257D3A0046AFC8/$file/18.8.2014.Cyprus_WHO_Report.pdf?OpenElement.
   Google Scholar
• Lionis C, Petelos E, Shea S, Bagiartaki G, Tsiligianni IG, Kamekis A, et al.Irrational prescribing of over-the-counter (OTC) medicines in general practice: testing the feasibility of an educational intervention among physicians in five European countriesBMC Fam Pract2014151115 10.1186/1471-2296-15-34
   PubMedGoogle Scholar
• Kringos D, Boerma W, Bourgueil Y, Cartier T, Dedeu T, Hasvold T, et al.The strength of primary care in Europe: an international comparative studyBr J Gen Pract201363616e742e750 10.3399/bjgp13X674422 24267857 3809427
   PubMed Web of Science ®Google Scholar
• Roberts E, Nunes VD, Buckner S, Latchem S, Constanti M, Miller P, et al.Paracetamol: not as safe as we thought? A systematic literature review of observational studiesAnn Rheum Dis2016753552559 1:CAS:528:DC%2BC28XitFGnur3E 10.1136/annrheumdis-2014-206914 25732175
   PubMed Web of Science ®Google Scholar
• Moore N, Van Ganse E, Le Parc JM, Wall R, Schneid H, Farhan M, et al.The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. A large-scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesiaClin Drug Investig19991828998 1:CAS:528:DyaK1MXlvVansrs%3D 10.2165/00044011-199918020-00001
   Web of Science ®Google Scholar
• Lau SM, McGuire TM, Van Driel MLConsumer concerns about paracetamol: a retrospective analysis of a medicines call centreBMJ Open20166618 10.1136/bmjopen-2015-010860
   Web of Science ®Google Scholar
• Kontogiorgis C, Nena E, Berberoglou E, Moschoni K, Polyzois S, Tselemponis A, et al.Estimating consumers’ knowledge and attitudes towards over-the-counter analgesic medication in Greece in the years of financial crisis: the case of paracetamolPain Ther2016511928 10.1007/s40122-015-0042-x 26696539
   PubMedGoogle Scholar
• Mccaul FIN, Hersch C, Kochhar S, Maguire T, Tisman A, Brown ADo pharmacists’ perceptions of OTC analgesia reflect existing evidence?SelfCare J20191037992
   Google Scholar
• Gilbertson RJ, Harris E, Pandey SK, Kelly P, Myers WParacetamol use, availability, and knowledge of toxicity among British and American adolescentsArch Dis Child199675194198 1:STN:280:DyaK2s7jtFSjtg%3D%3D 10.1136/adc.75.3.194 8976656 1511696
   PubMed Web of Science ®Google Scholar
• Bernal W, Auzinger G, Dhawan A, Wendon JAcute liver failureLancet20103769736190201 10.1016/S0140-6736(10)60274-7 20638564
   PubMed Web of Science ®Google Scholar
• Perkins JDAcetaminophen sets records in the United States: Number 1 analgesic and number 1 cause of acute liver failureLiver Transpl.200612682686 10.1002/lt.20735 16555331
   PubMed Web of Science ®Google Scholar
• Acetaminophen—LiverTox—NCBI bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK548162/. Accessed 1 Aug 2022.
   Google Scholar
• Tittarelli R, Pellegrini M, Scarpellini MG, Marinelli E, Bruti V, Di Luca NM, et al.Hepatotoxicity of paracetamol and related fatalitiesEur Rev Med Pharmacol Sci201721195101 1:STN:280:DC%2BC1cvkvVCitQ%3D%3D 28379590
   PubMed Web of Science ®Google Scholar
• FDA Risk Management Advisory Committee. Acetaminophen overdose and liver injury—background and options for reducing injury. 2009. https://www.regulations.gov/document/FDA-2011-N-0021-0004. Accessed 4 Aug 2022.
   Google Scholar
• Vitols SParacetamol hepatotoxicity at therapeutic dosesJ Intern Med200325329598 1:CAS:528:DC%2BD3sXhslWgu74%3D 10.1046/j.1365-2796.2003.01107.x 12542548
   PubMed Web of Science ®Google Scholar
• Building theoretical and empirical bridges across levels: multilevel research in management on JSTOR. https://www.jstor.org/stable/20159480. Accessed 3 May 2023.
   Google Scholar
• Cyprus Statistical Service—Publications. https://www.cystat.gov.cy/en/PublicationList?s=46. Accessed 1 Aug 2022.
   Google Scholar
• Sample size calculator by Raosoft, Inc. http://www.raosoft.com/samplesize.html. Accessed 29 July 2022.
   Google Scholar
• Morris HBasic statistics: a modern approach19853San DiegoHarcourt Brace Jovanovich548
   Google Scholar
• IBM Corp. Released 2021. IBM SPSS statistics for windows, version 28.0. Armonk: IBM Corp.
   Google Scholar
• Mostafa EMA, Tawfik AM, Abd-Elrahman KMEgyptian perspectives on potential risk of paracetamol/acetaminophen-induced toxicities: lessons learnt during COVID-19 pandemicToxicol Rep202120229541548
   Google Scholar
• Herndon CM, Dankenbring DMPatient perception and knowledge of acetaminophen in a large family medicine serviceJ Pain Palliat Care Pharmacother2014282109116 10.3109/15360288.2014.908993 24813653
   PubMedGoogle Scholar
• Fosnocht D, Taylor JR, Caravati EMEmergency department patient knowledge concerning acetaminophen (paracetamol) in over-the-counter and prescription analgesicsEmerg Med J2008254213216 1:STN:280:DC%2BD1c7pslGqsA%3D%3D 10.1136/emj.2007.053850 18356351
   PubMed Web of Science ®Google Scholar
• Hurwitz J, Sands S, Davis E, Nielsen J, Warholak TPatient knowledge and use of acetaminophen in over-the-counter medicationsJ Am Pharm Assoc20145411926 10.1331/JAPhA.2014.13077
   Google Scholar
• FDA. FDA drug safety communication: prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. FDA. 2011. http://www.fda.gov/Drugs/DrugSafety/ucm239821.htm.
   Google Scholar
• Gulmez SE, Larrey D, Pageaux GP, Bernuau J, Bissoli F, Horsmans Y, et al.Liver transplant associated with paracetamol overdose: results from the seven-country SALT studyBr J Clin Pharmacol2015803599606 1:CAS:528:DC%2BC2MXhsVegs73J 10.1111/bcp.12635 26017643 4574844
   PubMed Web of Science ®Google Scholar
• Kim J, Kinney K, Nyquist M, Capellari E, Vordenberg SEFactors that influence how adults select oral over-the-counter analgesics: a systematic reviewJ Am Pharm Assoc202262111 10.1016/j.japh.2022.03.007
   Google Scholar
• Tariq M, Din FUPoor knowledge of university students regarding paracetamol; a wakeup call for public healthcare practitionersCogent Med2017411320848 10.1080/2331205X.2017.1320848
   Google Scholar
• Håkonsen H, Hedenrud TA population-based study of risk perceptions of paracetamol use among Swedes—with a special focus on young adultsPharmacoepidemiol Drug Saf2017268992997 10.1002/pds.4238 28585409
   PubMed Web of Science ®Google Scholar
• Chong CP, Tan SF, Chooi WTExploring consumers’ perceptions and knowledge of acetaminophen (paracetamol): a cross-sectional study from Penang, MalaysiaInt J Pharma Sci Res202011035257 1:CAS:528:DC%2BB3cXisFeju7zP
   Google Scholar
• Stumpf JL, Skyles AJ, Alaniz C, Erickson SRKnowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic populationJ Am Pharm Assoc20034713541 10.1331/1544-3191.47.1.35.Stumpf
   Google Scholar
• Hornsby LB, Whitley HP, Hester EK, Thompson M, Donaldson ASurvey of patient knowledge related to acetaminophen recognition, dosing, and toxicityJ Am Pharm Assoc2010504485489 10.1331/JAPhA.2010.08175
   Google Scholar
• Ip EJ, Tang TTL, Cheng V, Yu J, Cheongsiatmoy DSImpact of educational levels and health literacy on community acetaminophen knowledgeJ Pharm Pract2015286499503 10.1177/0897190014544819 25112303
   PubMedGoogle Scholar
• Kaufman DW, Kelly JP, Rohay JM, Malone MK, Weinstein RB, Shiffman SPrevalence and correlates of exceeding the labeled maximum dose of acetaminophen among adults in a US-based internet surveyPharmacoepidemiol Drug Saf2012211219 10.1002/pds.3350
   Web of Science ®Google Scholar
• European Medicines Agency. Modified-release paracetamol-containing products to be suspended from EU market. 2018;44:2–5. www.ema.europa.eu/contact.
   Google Scholar
• Morthorst BR, Erlangsen A, Nordentoft M, Hawton K, Hoegberg LCG, Dalhoff KPAvailability of paracetamol sold over the counter in Europe: a descriptive cross-sectional international survey of pack size restrictionBasic Clin Pharmacol Toxicol20181226643649 1:CAS:528:DC%2BC1cXisVSrsrY%3D 10.1111/bcpt.12959 29319222
   PubMed Web of Science ®Google Scholar
• Morthorst BR, Erlangsen A, Chaine M, Eriksson F, Hawton K, Dalhoff K, et al.Restriction of non-opioid analgesics sold over-the-counter in Denmark: a national study of impact on poisoningsJ Affect Disord20202686168 10.1016/j.jad.2020.02.043 32158008
   PubMed Web of Science ®Google Scholar
• Antoniou T, Guan Q, Martins D, Gomes TImpact of acetaminophen product labelling changes in Canada on hospital admissions for accidental acetaminophen overdose: a population-based studyCMAJ202219415E542E548 10.1503/cmaj.210842 35440502 9028412
   PubMed Web of Science ®Google Scholar
• Morgan O, Griffiths C, Majeed AImpact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational studyJ Public Health20052711924 10.1093/pubmed/fdh216
   Google Scholar